OBJECTIVES: There is no pharmacokinetic interaction between tenofovir and nevirapine, but a higher emergence rate of resistance mutations has been reported when these drugs are coadministered. We sought to examine if there is a potential intracellular interaction that may account for the emergence of resistant virus. METHODS: Primary CD4+ and CD14+ cells were isolated from healthy volunteer blood. Monocyte-derived macrophages were differentiated from CD14+ cells. Accumulation of radiolabelled tenofovir and nevirapine was then assessed in these cells. RESULTS: We show here that tenofovir and nevirapine immune cell intracellular concentrations are lower when coincubated in CD4+ cells and monocyte-derived macrophages, but not in CD14+ cells. CONCLUSIONS: These data indicate a potential intracellular drug-drug interaction between these drugs that warrants further investigation.
OBJECTIVES: There is no pharmacokinetic interaction between tenofovir and nevirapine, but a higher emergence rate of resistance mutations has been reported when these drugs are coadministered. We sought to examine if there is a potential intracellular interaction that may account for the emergence of resistant virus. METHODS: Primary CD4+ and CD14+ cells were isolated from healthy volunteer blood. Monocyte-derived macrophages were differentiated from CD14+ cells. Accumulation of radiolabelled tenofovir and nevirapine was then assessed in these cells. RESULTS: We show here that tenofovir and nevirapine immune cell intracellular concentrations are lower when coincubated in CD4+ cells and monocyte-derived macrophages, but not in CD14+ cells. CONCLUSIONS: These data indicate a potential intracellular drug-drug interaction between these drugs that warrants further investigation.
Entities:
Keywords:
HIV; drug–drug interactions; influx drug transporters
Authors: K Bleasby; J C Castle; C J Roberts; C Cheng; W J Bailey; J F Sina; A V Kulkarni; M J Hafey; R Evers; J M Johnson; R G Ulrich; J G Slatter Journal: Xenobiotica Date: 2006 Oct-Nov Impact factor: 1.908
Authors: Johanna Weiss; Johanna Rose; Caroline Henrike Storch; Nahal Ketabi-Kiyanvash; Alexandra Sauer; Walter Emil Haefeli; Thomas Efferth Journal: J Antimicrob Chemother Date: 2007-01-03 Impact factor: 5.790
Authors: Sudeep P Pushpakom; Neill J Liptrott; Sonia Rodríguez-Nóvoa; Pablo Labarga; Vincent Soriano; Marta Albalater; Elizabeth Hopper-Borge; Stefano Bonora; Giovanni Di Perri; David J Back; Saye Khoo; Munir Pirmohamed; Andrew Owen Journal: J Infect Dis Date: 2011-07-01 Impact factor: 5.226
Authors: Neill J Liptrott; Sudeep Pushpakom; Christoph Wyen; Gerd Fätkenheuer; Christian Hoffmann; Stefan Mauss; Heribert Knechten; Norbert H Brockmeyer; Elizabeth Hopper-Borge; Marco Siccardi; David J Back; Saye H Khoo; Munir Pirmohamed; Andrew Owen Journal: Pharmacogenet Genomics Date: 2012-01 Impact factor: 2.089
Authors: Caroline Henrike Storch; Robert Ehehalt; Walter Emil Haefeli; Johanna Weiss Journal: J Pharmacol Exp Ther Date: 2007-07-24 Impact factor: 4.030
Authors: Kimberly K Scarsi; Geoffrey Eisen; Kristin M Darin; Seema T Meloni; Holly E Rawizza; Eric J Tchetgen Tchetgen; Oche O Agbaji; Daniel I Onwujekwe; Wadzani Gashau; Reuben Nkado; Prosper Okonkwo; Robert L Murphy; Phyllis J Kanki Journal: Clin Infect Dis Date: 2015-11-10 Impact factor: 9.079